找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Progress in Cancer Immunotherapy; Shuren Zhang Book 2016 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sprin

[復制鏈接]
查看: 17118|回復: 35
樓主
發(fā)表于 2025-3-21 17:39:12 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Progress in Cancer Immunotherapy
編輯Shuren Zhang
視頻videohttp://file.papertrans.cn/761/760338/760338.mp4
概述Provides readers with recent progress in basic and clinical research of cancer immunotherapy.Covers hot topics in cancer immunotherapy, such as cancer vaccines, monoclonal antibodies and adoptive cell
叢書名稱Advances in Experimental Medicine and Biology
圖書封面Titlebook: Progress in Cancer Immunotherapy;  Shuren Zhang Book 2016 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sprin
描述.Thisbook provides readers an extensive overview of?recent progress in basicand clinical research on cancer immunotherapy. Thanks to rapid advances inmolecular biology and immunology, it has become increasingly evident thatcancer growth is influenced by host immune responses. With the success of anumber of clinical trials, immunotherapy has become a promising treatmentmodality of cancer. This book covers five major topics, including monoclonalantibodies, biological response modifiers, cancer vaccines, adoptive cellulartherapy and oncolytic viruses. It also examines the combination of differentimmune strategies as well as?the combination of immunotherapy with othertreatments to increase anti-tumor effects. Throughthecomprehensive discussion of the topic, the book sheds valuable new light on thetreatment of tumors..
出版日期Book 2016
關(guān)鍵詞Antibody; Cancer immunotherapy; Cellular immunotherapy; Oncolytic virus; Vaccine; antibodies; vaccines
版次1
doihttps://doi.org/10.1007/978-94-017-7555-7
isbn_softcover978-94-024-1379-3
isbn_ebook978-94-017-7555-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature B.V. 201
The information of publication is updating

書目名稱Progress in Cancer Immunotherapy影響因子(影響力)




書目名稱Progress in Cancer Immunotherapy影響因子(影響力)學科排名




書目名稱Progress in Cancer Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Progress in Cancer Immunotherapy網(wǎng)絡(luò)公開度學科排名




書目名稱Progress in Cancer Immunotherapy被引頻次




書目名稱Progress in Cancer Immunotherapy被引頻次學科排名




書目名稱Progress in Cancer Immunotherapy年度引用




書目名稱Progress in Cancer Immunotherapy年度引用學科排名




書目名稱Progress in Cancer Immunotherapy讀者反饋




書目名稱Progress in Cancer Immunotherapy讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:10:40 | 只看該作者
第160338主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 01:07:38 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 07:35:52 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 11:39:26 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 16:55:27 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 20:50:56 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 23:18:46 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 03:25:03 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 08:10:17 | 只看該作者
10樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 20:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
江阴市| 西峡县| 兴安县| 东乌珠穆沁旗| 沙田区| 鹿邑县| 五寨县| 阳原县| 海阳市| 驻马店市| 民丰县| 寻乌县| 泽库县| 远安县| 辽中县| 新巴尔虎右旗| 衢州市| 绥芬河市| 香格里拉县| 本溪市| 琼海市| 泌阳县| 绥江县| 独山县| 苏州市| 荥经县| 孝义市| 湖南省| 大同市| 乐清市| 毕节市| 奉新县| 灵石县| 朝阳区| 黎平县| 紫金县| 新津县| 济南市| 湖口县| 东安县| 潜山县|